CEO: | Daniel Lee |
CFO: | David Cocke |
Independent Non-Executive Director: | Brian Phillips |
Independent Non-Executive Director: | Trevor Phillips |
Non-Executive Chairman: | Jonathan Glenn |
Non-Executive Dir: | Shervanthi Homer - Vanniasinkam |
Address: | Unit 3, Phoenix Court, Lotherton Way, Garforth, United Kingdom, LS25 2GY |
Phone: | +44 (0) 1904 567 609 |
Fax: | +44 (0) 1904 380 517 |
Website: | http://www.tissueregenix.com/ |
Sector: | Financials(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BNTXR104 |
Currency | UK Pounds |
Share Price | 57.50p |
Change Today | -1.50p |
% Change | -2.54 % |
52 Week High | 74.00p |
52 Week Low | 50.40p |
Volume | 16,743 |
Shares Issued | 71.40m |
Market Cap | £41.05m |
Beta | 0.30 |
RiskGrade | 22 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:51 | 6 @ 56.00p |
13:51 | 10,000 @ 57.35p |
13:42 | 3,000 @ 56.26p |
13:33 | 1,276 @ 58.00p |
12:52 | 750 @ 58.00p |
You are here: research